Zogenix cuts 55 jobs, awaits FDA Zohydro decision
This article was originally published in Scrip
Executive Summary
Zogenix will reduce its 148-employee work force by 37%, cutting 55 jobs as the San Diego-based company awaits a US FDA decision on approval for the chronic pain drug Zohydro ER.